THE German-speaking market access experts - Austria, Germany, Switzerland
There is a big debate since years on the potential implementation of a joint HTA system across Europe. Core questions on such a system remains on how such an approach could look like and even more important be implemented. The webinar will summarize the current status of the debate and also suggest a way how such a joint HTA could be implemented in the European Union.
Register now: https://us02web.zoom.us/webinar/register/4715954498495/WN_8WnsBaNyQZKf4BFvtgBP4g
In a recent study funded by the Dutch government it was found that roughly 91% of start-ups fail! What are the reasons for that and more important how could you plan to be successful? MArS in cooperation with the Dutch consultancy Seijgraaf will present and discuss findings and solutions for a successful market access of health care start-ups. The webinar will include the following topics: • What are the major issues health care start-ups have when preparing to enter the launch? • What are must-haves in terms of market access and reimbursement for new products in the health care system? • How can a health care start-up be successful?
Germany has been seen at the forefront of the Covid-19 control and outcomes. The situation until end May is very promising with a reproduction number below one and new infections below 800 per day. Few hotspots have been identified and lock-down measures have been relaxed to a maximum. However, a core question remains: Not if, but when will a second wave of Covid-19 come and how will this potentially look like.
The MArS Covid-19 task force will present to you some realistic simulation scenarios based on epidemiological evidence.
The covid-19 outbreak has had a significant impact on daily life of populations and health care systems. Due to physical distancing as a core policy, digitalization is a main opportunity also in health care. At the same time the new law for digitalization in health care (DiGA) was made effective In Germany.
The MArS Covid-19 task force will show you in this webinar:
Register now: Webinars
On Thursday, April 23 2020, MArS offered the webinar “How many billion of Euros does the fight against the Covid-19-virus cost the healthcare system? A health economic modelling analysis for Germany”.
The presentation as a video is now available:
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
MArS has extensive experience in health economic modelling an support you in your endeavors.
Enjoy the video and stay healthy!
On Thursday, April 23 2020, MArS offered the webinar “How many billion of Euros does the fight against the Covid-19-virus cost the healthcare system? A health economic modelling analysis for Germany”.
The presented slides are now available on our website MArS – Stefan Walzer – Webinar – Covid-19 impact health economics Germany
MArS has extensive experience in health economic modelling an support you in your endeavors.
Stay healthy!
The covid-19 outbreak has had a significant impact on daily life of populations and also a significant budget impact for health care systems. There are various statistical simulation tools available in the context of Covid-19 developed by different institutions. The CovidSIM is a simulator developed by academic experts on behalf of the ministry of social welfare (and health) of Baden-Wuerttemberg (Germany).
The MArS Covid-19 task force will show you in this webinar:
• How well this simulator can predict the outbreak and situation in Germany.
• How much the health care utilization cost have been so far for the German health care system.
• In which way you might leverage this simulation tool.
Register now – seats are limited: https://zoom.us/webinar/register/4915870254563/WN_q4mgDCXVRAiD_ZrYUgsSKQ
Please contact us directly and get your tailor-made solution to stay in contact with your KOLs: stefan.walzer@marketaccess-pricingstrategy.de
The G-BA has decided today that the COVID-19 outbreak and the related public restrictions are special circumstances in their internal regulations. Hence they can now also utilize videoconferences and written decision-making. See also details on their website. Their decision is still due until the Ministry of Health decides on the resolution.
So, the market access route for drugs, medical devices, diagnostics, vaccinations is still open and ready for (new) innovations.
MArS has vast experience in market access strategy, the writing of applications and related price negotiations. Contact us!
Dear clients, network partners, friends!!
Most of companies are moving now into home-office-based business given the outbreak of the COVID-19 virus! Home-office sounds easy, it is not always, especially if you have not (yet) a grown culture on that kind of work.
We at MArS always work from our home-offices, and we have specific tricks and recommendations you need to follow in order to make it successful! On the work environment section of our website you can find already some suggestions.
But please take this as an offer: Contact me or any MArS member to get insights how home-office can be made a successful story given the difficult situation we are currently all in.
Take care and stay at home!!
